Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03369652
Other study ID # OP_468
Secondary ID 1704197
Status Completed
Phase N/A
First received
Last updated
Start date November 24, 2017
Est. completion date November 30, 2018

Study information

Verified date March 2019
Source Odense University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this trial, the feasibility of cooperation between clinical pharmacists and physicians by conducting a telephone follow-up conversation between the hospital geriatrician, the general practitioner and the clinical pharmacist is evaluated. During hospital stay the clinical pharmacist and the geriatrician will review older patients' medication and discuss the future treatment with the general practitioner after discharge by telephone or medico-technology.

The first part of the feasibility study will be a qualitative baseline measure of characteristics of the participants and work flow. The second part will be a pilot randomized controlled study where participants will be allocated to either usual care or medication review and follow up contact


Recruitment information / eligibility

Status Completed
Enrollment 232
Est. completion date November 30, 2018
Est. primary completion date November 1, 2018
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria:

* 5 drugs or more

Exclusion Criteria:

- Terminal illness

- Not able to speak and understand Danish

Study Design


Intervention

Behavioral:
Medication review
Conducted by the pharmacist and discussed with hospital physician

Locations

Country Name City State
Denmark Odense University Hospital Odense
Denmark Svendborg Sygehus Svendborg

Sponsors (1)

Lead Sponsor Collaborator
Odense University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in number of medications Increase or decrease in number of medications from admission to discharge At admission and at discharge
Primary Parts of the intervention completed In the intervention Group only, it is measured, how many of the elements of the intervention the patient actually have received Day 1 after discharge
Primary Changes in the Electronic Medication Profile (FMK) How many changes have been Applied to the Electronic Medication Profile 14 days after discharge
Secondary Number of readmissions Data from registers within 30 days after discharge
Secondary Number of emergency visits Data from registers within 30 days after discharge
Secondary Number of visits at general practitioner Data from registers within 30 days after discharge
Secondary Patient satisfaction with the discharge Measured by telephone interview 14 days after discharge
Secondary Changes in patient-experienced quality of life Measured by telephone interview using the 5-item questionnaire EQ-5D, where each question can be answered on a 5-point Likert Scale ranging from "very high degree of problems" to "very low degree of problems" At admission and 14 days after discharge
Secondary Health care professionals satisfaction Measured by a questionnaire 3 months after implementation
See also
  Status Clinical Trial Phase
Completed NCT04085796 - ICCI for Older Patients in A&E
Completed NCT03199768 - Delirium in Geriatric Hospital Single-bed and Multibed Rooms
Recruiting NCT05084027 - Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT Phase 2
Not yet recruiting NCT05537155 - Buccal Acupuncture for Delirium Treatment in Older Patients Recovering From Orthopedic Surgery N/A
Completed NCT03881137 - Improved Function and Quality of Life for Older Patients Receiving Radiotherapy, Part II N/A
Recruiting NCT06044623 - Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients Phase 3
Recruiting NCT05765370 - LDL Cholesterol TARGETs in OLDer Patients (Ageā‰„75 Years) With ASCVD (TARGET OLD) N/A
Not yet recruiting NCT06275958 - DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients With Metastatic Colorectal Cancer Phase 3
Completed NCT03382054 - Frailty and Post-operative Complications in Older Surgical Patients: The Implication of Frailty and Preoperative Risk Assessment
Recruiting NCT05150249 - Prospective Observational Study Based on a Cohort of Geriatric Patients With Hip Fracture Treated in the Centers Belonging to the GIOG Group
Active, not recruiting NCT05907694 - Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure N/A